Protocol Ledger

NCT06174402 · Phase II/III · ACTIVE NOT RECRUITING

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Interventional Phase II/III clinical trial protocol NCT06174402 sponsored by Han Ying in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-08-21 Enrollment: 184 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06174402
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)184 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06174402
Protocol FieldVerified Registry Value
NCT IdentifierNCT06174402
Consolidated Lead SponsorHan Ying
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II/III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment184 participants (ESTIMATED)
Registered Start Date2023-08-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI